Share this Job

Senior Scientist

Req ID:  40109
Location: 

Harlow, ESS, GB

For nearly 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Due to our continued growth we have an exciting opportunity for a talented, highly motivated individual at our state of the art drug discovery site in Harlow.

 

The appointed Senior Scientist will be a key member of the Discovery Biology Operational Team providing strong scientific leadership to project teams in the Harlow Biology Department.  

 

You will already have significant experience as a Drug Discovery Scientist in an industrial setting, ideally within a CRO environment, as the role includes responsibility for managing drug discovery projects. Excellent interpersonal skills and the ability to motivate project teams are vital for this key role.

 

You will be familiar with all aspects of drug discovery (including HTS, biomarker strategies and development of appropriate screening cascades), will preferably have a strong background in immunology, oncology and be able to work across therapeutic areas in order to apply these skills to ongoing and new projects. A dynamic and flexible approach towards achieving client-based objectives and meeting challenging deadlines is required, as is the ability to communicate confidently and concisely with clients via teleconferences, presentations and written reports.

 

In addition to leading your own projects, you will be comfortable communicating across CRL sites in order to drive efficiencies and enhance best practise.

 

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.

For more information, please visit www.criver.com.